|
| |
BioPortfolio's Approved Drugs DatabaseTemodarTemozolomideDownload PDF containing detailed information.
Press Releases About Temodar:
|
 |
| TRACON Pharmaceuticals' Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009 |
26th May, 2009 |
TRACON Pharmaceuticals, Inc. |
SAN DIEGO, May 26 /PRNewswire/ -- TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and related diseases, announced today that Phase 1 clinical results from
|
| Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting |
26th May, 2009 |
Ascenta Therapeutics |
MALVERN, Pa., May 26 /PRNewswire/ -- Ascenta Therapeutics announced today that eleven presentations or publications on pre-clinical and clinical studies of AT-101, an oral, pan-Bcl-2 inhibitor, in
|
| Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Grade Glioma |
9th March, 2009 |
Decision Resources |
A Drug That Improves Survival, When Added to Temodar/Temodal, Would Earn a 65 Percent Patient Share in the U.S. and a 30 Percent Patient Share in Europe in Newly Diagnosed Glioblastoma Multiforme,
|
| Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer |
27th February, 2009 |
Ascenta Therapeutics |
- Data presented today at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium -
MALVERN, Pa., Feb. 27 /PRNewswire/ -- Ascenta Therapeutics announced today positive
|
| A Stage IV Malignant Melanoma Drug That Increases Overall Survival Would Earn a Higher Patient Share in the U.S. Than in Europe |
19th January, 2009 |
Decision Resources |
Ipilimumab Will Earn Decision Resources' Clinical Gold Standard for Stage IV Malignant Melanoma in 2012, According to a New Report from Decision Resources
WALTHAM, Mass., Jan. 19 /PRNewswire/ --
|
This page has been viewed 25 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Temodar across BioPortfolio, or for Temodar Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
